Iyunithi yenkampani yaseJapan esekelwa nguPhilip Morris International ihlela ukwethula umuthi wokugomela i-Covid-19 wokuqala osekelwe esitshalweni okungenzeka ushibhile futhi kulula ukuwuthwala nokuyigcina kune-jabs evamile.
UToshifumi Tada, inhloko yezokuthuthukiswa kwebhizinisi lokugoma kwaMitsubishi Tanabe Pharma, uthe inkampani engaphansi kwayo iMedicago izofaka isicelo sokugunyazwa eCanada ukuze ithole umuntu ozogoma owenziwe esitshalweni esiphuma emndenini kagwayi ekupheleni kwalo nyaka.
Iqembu lezemithi elizinze e-Osaka lilindele isidingo somhlaba wonke sokuthi imigomo ye-Covid ihlale iqinile njengoba izinhlobo ezintsha ze-coronavirus ziqhubeka nokuvela, linikeze ithuba lokungena emakethe ebibuswa ngabaphambili abanjengoPfizer, Moderna, kanye ne-AstraZeneca.
“Njengomkhuhlane wesizini, asilindele ukuthi isidingo [semigomo ye-Covid] sinyamalale kungazelelwe, futhi kusenokungaqiniseki okuningi mayelana nezinhlobonhlobo ezivelayo,” kusho uTada. "Sikholelwa ukuthi kunenzuzo ekwandiseni izinketho zemithi yokugoma."
Awukho umuthi wokugoma osuselwe ezitshalweni ogunyaziwe ukuthi usetshenziswe kubantu, kodwa abasekeli balobu buchwepheshe bathi imithi yokugoma enjalo iyathandeka ngoba amaqabunga ezitshalo akhula ngokushesha, afinyeze inqubo yokukhiqiza futhi ehlise nezindleko. Ukukhiqizwa okusheshayo, bangeze, kwenza kube lula ukuzivumelanisa nokulwa nezinhlobo ezintsha.